Explainable Insulin Decision-making System to Assist Physicians in Diabetes Management

Launched by SHANGHAI ZHONGSHAN HOSPITAL · May 23, 2024

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Case:
• Inclusion Criteria:
• • Patients with T2DM who were admitted to Zhongshan Hospital of Fudan University from 2022.12 to 2023.3.
• • Insulin regimen is one of the following: a. Basal regimen: once a day subcutaneous injection of long-acting or ultra-long-acting insulin; b. Premixed regimen: two/three times a day subcutaneous injection of premixed insulin; c. Basal mealtime regimen: three times a day before meals subcutaneous injection of short-acting or rapid-acting insulin, plus once a day injection of long-acting or ultra-long-acting insulin.
• Exclusion Criteria:
• • - Cases will be excluded if there is insufficient information for a valid assessment (missing data on insulin or blood glucose \>40%).
• • Doctor
• Inclusion Criteria:
• • licensed medical practitioner.

Trial Officials